Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLSI Greenwich Lifesciences Inc

未开盘 11-21 16:00:00 EST

12.97

+0.12

+0.93%

盘后13.25

+0.28+2.16%

16:16 EST

最高13.44	最低12.51	成交量3.91万
今开12.97	昨收12.85	日振幅7.25%
总市值1.70亿	流通市值7,684万	总股本1,314万
成交额50.14万	换手率0.66%	流通股本592.44万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLSI","market":"US","secType":"STK","nameCN":"Greenwich Lifesciences Inc","latestPrice":12.97,"timestamp":1732222800000,"preClose":12.85,"halted":0,"volume":39060,"hourTrading":{"tag":"盘后","latestPrice":13.25,"preClose":12.97,"latestTime":"16:16 EST","volume":509,"amount":6741.8496,"timestamp":1732223783790},"delay":0,"floatShares":5924355,"shares":13144653,"eps":-0.811102,"marketStatus":"未开盘","marketStatusCode":0,"change":0.12,"latestTime":"11-21 16:00:00 EST","open":12.97,"high":13.4427,"low":12.5106,"amount":501374.92167,"amplitude":0.072537,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.811102,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1601006400000,"adjPreClose":12.85,"postHourTrading":{"tag":"盘后","latestPrice":13.25,"preClose":12.97,"latestTime":"16:16 EST","volume":509,"amount":6741.8496,"timestamp":1732223783790},"volumeRatio":1.254408},"requestUrl":"/m/hq/s/GLSI","defaultTab":"news","newsList":[{"id":"2484972467","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484972467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484972467?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:32","pubTimestamp":1732044737,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时32分，Greenwich Lifesciences, Inc.股票出现波动，股价快速上涨6.06%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120033217abcfed1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120033217abcfed1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2483778133","title":"Greenwich Lifesciences, Inc.盘中异动 早盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483778133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483778133?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681112,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Greenwich Lifesciences, Inc.股票出现波动，股价急速拉升5.30%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522315295be342b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522315295be342b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2483334930","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大涨5.92%报14.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483334930?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:18","pubTimestamp":1731615480,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时18分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅拉升5.92%。截至发稿，该股报14.14美元/股，成交量1.337万股，换手率0.10%，振幅5.63%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041800abc2078e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115041800abc2078e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2483892836","title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483892836","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483892836?lang=zh_cn&edition=full","pubTime":"2024-11-14 11:58","pubTimestamp":1731556695,"startTime":"0","endTime":"0","summary":"   * 格林威治生命科学公司   预计在11月15日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG的分析师平均预计格林威治生命科学公司每股亏损21美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对格林威治生命科学公司 12 个月目标价的中位数为 38.00 美元，高于其最后收盘价 13.35 美元。11月14日 - 本摘要于北京时间11月14日03:57由机器生成。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI"],"gpt_icon":0},{"id":"2482266763","title":"Greenwich Lifesciences, Inc.盘中异动 大幅下挫5.00%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482266763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482266763?lang=zh_cn&edition=full","pubTime":"2024-11-12 04:46","pubTimestamp":1731358017,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日04时46分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下跌5.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204465798e41e14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111204465798e41e14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2482432628","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘大幅拉升5.13%报14.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482432628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482432628?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:34","pubTimestamp":1731094446,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日03时34分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅拉升5.13%。截至发稿，该股报14.52美元/股，成交量1.0026万股，换手率0.08%，振幅3.20%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110903340698e418e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110903340698e418e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2481305121","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.55%报13.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481305121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481305121?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:53","pubTimestamp":1731005622,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时53分，Greenwich Lifesciences, Inc.股票出现异动，股价快速下挫5.55%。截至发稿，该股报13.62美元/股，成交量1.1434万股，换手率0.09%，振幅4.65%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108025343a2216c73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108025343a2216c73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2481964544","title":"格林威治生命科学公司  预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481964544","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481964544?lang=zh_cn&edition=full","pubTime":"2024-11-07 07:22","pubTimestamp":1730935323,"startTime":"0","endTime":"0","summary":"格林威治生命科学公司  预计每股亏损 21 美分 - 财报前瞻格林威治生命科学公司GLSI.OQ GLSI.O预计在11月8日公布截至2024年9月30日的业绩报告时，季度收入将没有变化(预计)。LSEG的分析师平均预计格林威治生命科学公司每股亏损21美分。华尔街对格林威治生命科学公司 12 个月目标价的中位数为 38.00 美元，高于其最新收盘价 14.42 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD3LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI"],"gpt_icon":0},{"id":"2481846506","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481846506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481846506?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:06","pubTimestamp":1730822760,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日00时06分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水6.42%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600060098e4096e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600060098e4096e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2479612034","title":"Greenwich Lifesciences, Inc.盘中异动 早盘大幅下跌5.28%报13.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479612034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479612034?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:47","pubTimestamp":1730386067,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时47分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水5.28%。截至发稿，该股报13.63美元/股，成交量8277股，换手率0.06%，振幅3.60%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为3.55%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122474798e3fc0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122474798e3fc0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2479748820","title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479748820","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479748820?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:29","pubTimestamp":1730345365,"startTime":"0","endTime":"0","summary":"   * 格林威治生命科学公司   预计在11月1日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG的分析师平均预计格林威治生命科学公司每股亏损21美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对格林威治生命科学公司 12 个月目标价的中位数为 38.00 美元，高于其最新收盘价 14.39 美元。10月31日 - 本摘要于北京时间 10 月 31 日 03:28 编辑。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI"],"gpt_icon":0},{"id":"2479943149","title":"Greenwich Lifesciences, Inc.盘中异动 快速拉升5.19%报14.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479943149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479943149?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:16","pubTimestamp":1730132167,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日00时16分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅上涨5.19%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029001607971a2b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029001607971a2b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2477545951","title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2477545951","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477545951?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:53","pubTimestamp":1729738383,"startTime":"0","endTime":"0","summary":"   * 格林威治生命科学公司   预计在10月25日公布截至2024年9月30日的业绩时，季度收入将没有变化(预计)。*    * LSEG的分析师平均预计格林威治生命科学公司每股亏损21美分。* 分析师对该公司股票的评级为 \"买入\"。* 华尔街对格林威治生命科学公司 12 个月目标价的中位数为 38.00 美元，高于其最后收盘价 13.59 美元。10月24日 - 本摘要于北京时间 10 月 24 日 02:52 机器生成。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"格林威治生命科学公司    预计每股亏损 21 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI"],"gpt_icon":0},{"id":"2476299084","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大跌5.00%报13.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476299084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476299084?lang=zh_cn&edition=full","pubTime":"2024-10-19 02:17","pubTimestamp":1729275424,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日02时17分，Greenwich Lifesciences, Inc.股票出现波动，股价急速跳水5.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019021704ab6b36b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019021704ab6b36b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2474495580","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474495580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474495580?lang=zh_cn&edition=full","pubTime":"2024-10-12 03:03","pubTimestamp":1728673435,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日03时03分，Greenwich Lifesciences, Inc.股票出现异动，股价快速上涨5.43%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101203035598e3bf21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101203035598e3bf21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2474209164","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.76%报12.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474209164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474209164?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:51","pubTimestamp":1728503494,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时51分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅下挫5.76%。截至发稿，该股报12.77美元/股，成交量2.5174万股，换手率0.19%，振幅5.09%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100351359719f51f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100351359719f51f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2472172126","title":"Greenwich Lifesciences, Inc.盘中异动 早盘大幅下挫5.08%报13.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472172126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472172126?lang=zh_cn&edition=full","pubTime":"2024-10-03 23:16","pubTimestamp":1727968598,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时16分，Greenwich Lifesciences, Inc.股票出现异动，股价急速下挫5.08%。截至发稿，该股报13.26美元/股，成交量1.8916万股，换手率0.14%，振幅5.73%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.04%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100323163898e3a716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100323163898e3a716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0},{"id":"2470767814","title":"Greenwich Lifesciences, Inc.盘中异动 临近收盘快速下挫5.85%报14.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470767814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470767814?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:55","pubTimestamp":1727380529,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时55分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下跌5.85%。截至发稿，该股报14.33美元/股，成交量2.0467万股，换手率0.16%，振幅5.39%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409270355299719ce37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409270355299719ce37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2468471502","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468471502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468471502?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:19","pubTimestamp":1726762767,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时19分，Greenwich Lifesciences, Inc.股票出现波动，股价快速上涨5.01%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920001927a1db3793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920001927a1db3793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"gpt_icon":0},{"id":"2467705234","title":"Greenwich Lifesciences, Inc.盘中异动 急速拉升5.26%报15.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467705234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467705234?lang=zh_cn&edition=full","pubTime":"2024-09-14 00:26","pubTimestamp":1726244798,"startTime":"0","endTime":"0","summary":"北京时间2024年09月14日00时26分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.26%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140026389719b56c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140026389719b56c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenwichlifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0456},{"period":"1month","weight":-0.0601},{"period":"3month","weight":-0.1284},{"period":"6month","weight":-0.0321},{"period":"1year","weight":0.1427},{"period":"ytd","weight":0.2329}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Greenwich LifeSciences, Inc.成立于2006年8月29日，是特拉华州的一家公司。该公司是一家生物制药公司，正在开发GP2，这是一种旨在预防术后乳腺癌复发的免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.021514},{"month":2,"riseRate":0.5,"avgChangeRate":0.021223},{"month":3,"riseRate":0.75,"avgChangeRate":0.154494},{"month":4,"riseRate":0.25,"avgChangeRate":-0.223385},{"month":5,"riseRate":0.5,"avgChangeRate":-0.037454},{"month":6,"riseRate":0.75,"avgChangeRate":0.088955},{"month":7,"riseRate":0,"avgChangeRate":-0.069692},{"month":8,"riseRate":0.5,"avgChangeRate":0.013055},{"month":9,"riseRate":0.25,"avgChangeRate":-0.018711},{"month":10,"riseRate":0,"avgChangeRate":-0.092025},{"month":11,"riseRate":0.6,"avgChangeRate":0.262189},{"month":12,"riseRate":0.5,"avgChangeRate":1.410996}],"exchange":"NASDAQ","name":"Greenwich Lifesciences Inc","nameEN":"Greenwich Lifesciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Greenwich Lifesciences Inc,GLSI,Greenwich Lifesciences Inc股票,Greenwich Lifesciences Inc股票老虎,Greenwich Lifesciences Inc股票老虎国际,Greenwich Lifesciences Inc行情,Greenwich Lifesciences Inc股票行情,Greenwich Lifesciences Inc股价,Greenwich Lifesciences Inc股市,Greenwich Lifesciences Inc股票价格,Greenwich Lifesciences Inc股票交易,Greenwich Lifesciences Inc股票购买,Greenwich Lifesciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}